<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230612058466N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-07-01</date_registration>
      <primary_sponsor>Ahvaz University of Medical Sciences</primary_sponsor>
      <public_title>The effect of nature-based sounds on nausea, vomiting, and stress</public_title>
      <acronym></acronym>
      <scientific_title>The effect of nature-based sounds on nausea, vomiting, and stress in Acute myeloid leukemia patients undergoing chemotherapy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>114</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/70678</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: The method of assigning the intervention to people is randomly and by the method of randomized permutation blocks with random block sizes of 4, 6 and 8 (using the table related to random permutations). The randomization list is prepared by a statistician. The intervention used in this research is allocated according to the randomized list by a person outside the study who is not aware of the research objectives and according to the corresponding codes in the sealed envelopes, Blinding description: After selecting the samples, none of the sampled people will know about the randomization and the process of allocation to the groups. The researcher is given a pre-prepared list and enters the patients into the study in the order of the list numbers. Similar headphones are given to the patients of both groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Acute myeloid leukemia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: An MP3 device containing different sounds based on nature will be provided to the patients of the intervention group. These sounds include: the sound of birds, the sound of rain, the sound of a stream, the sound of a waterfall, walking in the forest. This will be done for 7 days. During the chemotherapy period, patients will be placed on their bed in whatever position they feel more comfortable (semi-sitting or supine position) and will listen to the set of sounds using headphones for 30 minutes in their rooms. The sound of headphones (25-50 dB) is adjusted so that it is satisfactory for the person and does not cause discomfort and ear irritation. Intervention 2: Control group: Control group: An MP3 device without any sound will be provided to patients in the control group. This will be done for 7 days. During the chemotherapy period, patients will be placed on their bed in whatever position they feel more comfortable (semi-sitting or supine position) and will put headphones in their ears without music for 30 minutes in their rooms. All control group participants will receive usual care.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The study report will be provided to the University of Medical Sciences. Also, the study will be published as an article.

When:
After the approval of the thesis

To whom:
The results of the study will be accessible to the researchers and the target group.

Conditions:
If necessary, the unidentifiable file in SPSS software format will be provided to Jundishapur University of Medical Sciences.

Where to obtain:
Central Library of Jundishapur University of Medical Sciences, Ahvaz; Library of the Faculty of Nursing and Midwifery; Responsible author and supervisor (Parisa Sheini-Jaberi: psheinijaberi@yahoo.com)

How to obtain:
send messages by e-mail; Refer to libraries

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Shahram Molavynejad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Golestan St.</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6135715794</zip>
        <telephone>+98 61 3373 8070</telephone>
        <email>shahrambaraz@ajums.ac.ir</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Shahram Molavynejad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Golestan St.</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6135715794</zip>
        <telephone>+98 61 3373 8070</telephone>
        <email>shahrambaraz@ajums.ac.ir</email>
        <affiliation>Ahvaz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Consent to enter the study
Patients with recently diagnosed acute myeloid leukemia. (New cases)
Patients who will undergo chemotherapy for the first time.
Patients who have the same chemotherapy protocol.
Patients who are fully conscious and not under airway intubation.
Patients who are not in a critical health condition and listening to music is safe for them.
No current smoking
No drug addiction
Patients who do not have respiratory and psychological diseases diagnosed by a physician.
Ability to read and write
Patients who are at least 18 years old.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients undergoing outpatient chemotherapy.
Patients with hearing impairment.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>C92.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Acute myeloid leukemia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: An MP3 device containing different sounds based on nature will be provided to the patients of the intervention group. These sounds include: the sound of birds, the sound of rain, the sound of a stream, the sound of a waterfall, walking in the forest. This will be done for 7 days. During the chemotherapy period, patients will be placed on their bed in whatever position they feel more comfortable (semi-sitting or supine position) and will listen to the set of sounds using headphones for 30 minutes in their rooms. The sound of headphones (25-50 dB) is adjusted so that it is satisfactory for the person and does not cause discomfort and ear irritation.</i_keyword>
      <i_keyword>Control group: Control group: An MP3 device without any sound will be provided to patients in the control group. This will be done for 7 days. During the chemotherapy period, patients will be placed on their bed in whatever position they feel more comfortable (semi-sitting or supine position) and will put headphones in their ears without music for 30 minutes in their rooms. All control group participants will receive usual care.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The score of the Rhodes Nausea and Vomiting Severity Questionnaire is less than 9. The DASS-21 score for stress is less than 19. Timepoint: Before starting the intervention and then every day for 7 days. Method of measurement: Rhodes questionnaire to measure the severity and frequency of nausea and vomiting; DASS-21 questionnaire to measure stress.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The quality of life score of the patients is at a good level. Timepoint: Before starting the intervention; 7 days and 30 days after the start of the intervention. Method of measurement: Quality of Life Questionnaire-Core 30 (QLQ-C30).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Ahvaz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-05-27</approval_date>
        <contact_name>Research ethics committee of Ahvaz Jundi Shapur University of Medical Sciences</contact_name>
        <contact_address>Golestan St. Ahvaz Khouzestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
